96134-65-5,MFCD01898529
Catalog No.:AA019NA6

96134-65-5 | 2-(5-methyl-1,3,4-oxadiazol-2-yl)aniline

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA019NA6
Chemical Name:
2-(5-methyl-1,3,4-oxadiazol-2-yl)aniline
CAS Number:
96134-65-5
Molecular Formula:
C9H9N3O
Molecular Weight:
175.1873
MDL Number:
MFCD01898529
SMILES:
Cc1nnc(o1)c1ccccc1N
Properties
Computed Properties
 
Complexity:
176  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2009/58348,2009,A1Locationinpatent:Page/Pagecolumn156

[1]Diao,Pinhui;Ge,Yanqin;zhang,Wenpei;Xu,Chen;Zhang,Nannan;Guo,Cheng[TetrahedronLetters,2018,vol.59,#8,p.767-770]

[2]Qian,Peng;Sheng,Liangquan;Wang,Li;Wang,Zhicheng;Wang,Zhongwei;Zhang,Zhenlei;Zhou,Zhenghong[JournalofOrganicChemistry,2020,vol.85,#20,p.13029-13036]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:96134-65-5 Molecular Formula|96134-65-5 MDL|96134-65-5 SMILES|96134-65-5 2-(5-methyl-1,3,4-oxadiazol-2-yl)aniline
Catalog No.: AA019NA6
96134-65-5,MFCD01898529
96134-65-5 | 2-(5-methyl-1,3,4-oxadiazol-2-yl)aniline
This product is typically in stock,please click "Inquire" below or contact us at [email protected]for pricing and availability information.
Inquire
Technical Information
Catalog Number: AA019NA6
Chemical Name: 2-(5-methyl-1,3,4-oxadiazol-2-yl)aniline
CAS Number: 96134-65-5
Molecular Formula: C9H9N3O
Molecular Weight: 175.1873
MDL Number: MFCD01898529
SMILES: Cc1nnc(o1)c1ccccc1N
Properties
Complexity: 176  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.1  
Downstream Synthesis Route
1148122-15-9    96134-65-5    1148122-56-8 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2009/58348,2009,A1Locationinpatent:Page/Pagecolumn156

91-56-5    1068-57-1    96134-65-5 

[1]Diao,Pinhui;Ge,Yanqin;zhang,Wenpei;Xu,Chen;Zhang,Nannan;Guo,Cheng[TetrahedronLetters,2018,vol.59,#8,p.767-770]

[2]Qian,Peng;Sheng,Liangquan;Wang,Li;Wang,Zhicheng;Wang,Zhongwei;Zhang,Zhenlei;Zhou,Zhenghong[JournalofOrganicChemistry,2020,vol.85,#20,p.13029-13036]

Building Blocks More >
1171190-56-9
1171190-56-9
1-({3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}methyl)piperazine dihydrochloride
AA019NFD | MFCD11505610
721444-62-8
721444-62-8
2-methanesulfonamido-4-methylpentanoic acid
AA019NRN | MFCD06369236
121690-13-9
121690-13-9
1-[4-(propan-2-yl)phenyl]-1H-1,2,3,4-tetrazole-5-thiol
AA019O18 | MFCD06655442
847758-97-8
847758-97-8
2-bromo-5-[methoxy(methyl)sulfamoyl]benzoic acid
AA019O9B | MFCD06655894
863668-03-5
863668-03-5
(4-butylphenyl)(thiophen-2-yl)methanamine
AA019OGS | MFCD07339046
957023-29-9
957023-29-9
(1-Isobutyl-3,5-dimethyl-1h-pyrazol-4-yl)acetic acid
AA019OND | MFCD07348595
1052539-34-0
1052539-34-0
1-{[4-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-5-amine hydrochloride
AA019OSG | MFCD07689444
69145-57-9
69145-57-9
2-{[(propan-2-yl)carbamoyl]amino}benzoic acid
AA019P1W | MFCD00248827
51871-17-1
51871-17-1
propan-2-yl 3-aminopropanoate hydrochloride
AA019P96 | MFCD08457600
940271-56-7
940271-56-7
1-(Chloroacetyl)-5-(2-methyl-1,3-thiazol-4-yl)indoline
AA019PFV | MFCD09389741
Submit
© 2017 AA BLOCKS, INC. All rights reserved.